The Study of Long-term Outcomes of GR1802 in Patients With Chronic Rhinosinusitis With Nasal Polyps
Condition: Chronic Rhinosinusitis With Nasal Polyps Intervention: Drug: GR1802 injection Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials